Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW) -- Ignore unavailable to you. Want to Upgrade?

To: Stock Watcher who wrote (3288)	2/23/1999 11:23:00 AM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 52051

I think it's MM's law... Mister Murphy's Law???: No that's not right... what does MM stand for??? ROTFLMAO Jeff

To: Stock Watcher who wrote (3288)	2/23/1999 1:52:00 PM
From: blake roberts	Read Replies (1) \| Respond to of 52051

Xechem Announces the Launch of Its XetaPharm Interactive e-commerce-based Web Site NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--February 23, 1999--Xechem International, Inc. (OTC BB: ZKEM - news) today announced the launch of its fully-functioning, interactive e-commerce-based Web site designed to inform Internet users of the many benefits associated with Xechem's Nutraceutical Product Line through its subsidiary XetaPharm, Inc. Rather than building and maintaining a static Web site and hoping people somehow find it, Xechem has taken the innovative approach of viewing its Internet presence as an ever-evolving work-in-progress and marketing its Web site via high placement on major search engines. The XetaPharm Web site can be found at www.xetapharm.com David Holifield, President of the Internet Web site development company goFluid.com said, ''We're working closely with Dr. Pandey and other key personnel at Xechem to constantly update and refine the information on the Xetapharm site. At the same time, we're beginning to apply our proprietary strategy of winning Meta Tag keyword searches. For example, when a user types in the word ''garlic'' into a major search engine, we expect to place high on the responding query. We're out to win relevant keyword searches in order to assist Internet users find the Xetapharm site.'' Xechem is working to establish the XetaPharm Web Site as the single most important Internet resource for information relative to each neutraceutical product the Company manufacturers. ''Because we have based our entire company philosophy on the research, development and production of pharmaceutical and nutraceutical products from Naturally Occurring Sources, and because we look to Chinese and Indian Traditional Medicinal Plants to guide us, we are uniquely qualified to offer the highest quality products along with the most current information surrounding the health benefits associated with each of our products.'' Dr. Ramesh Pandey, President of Xechem International, Inc., went on to further state, ''Beware: Not all neutraceutical products are what they report to be. Strict pharmaceutical standards must be adhered to at all times to ensure purity, quality and to meet exact dosage requirements.'' XetaPharm's current Nutraceutical Product Line consists of GarlicOnce®, GinkgoOnce®, GinsengOnce®, and Gugulon(TM). These products are manufactured to the highest pharmaceutical standards. Xechem expects to build a market share for its nutraceutical products through its Internet presence. Xechem International is a pharmaceutical company that focuses on three complementary disciplines: pharmaceutical research, technology development and manufacture; nutraceutical research, development, and production of high-quality nutraceuticals; and contract laboratory research, analytical and microbiological services. Xechem relies on Chinese and Indian Traditional Medicinal Plants to fuel its research into new proprietary drug technologies. For further information, contact Ramesh C. Pandey at (732) 247-3300. This news release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks, uncertainties, including the ability of the Companies to successfully develop and commercialize their technologies, and other factors that may cause the actual results, performance or achievements of the Companies to be materially different from any future results, performance or achievements of the Companies expressed or implied by such forward-looking statements. Contact: Ramesh C. Pandey, 732/247-3300